BREAST CARCINOMA
Specimen laterality:
Procedure:
Lymph nodes sampling (required only if lymph nodes are present):
a Tumor site/location:
Histologic type of Invasive carcinoma:
Tumor focality (required only if more than one focus of invasive carcinoma present):
Tumor size (size of largest invasive carcinoma, if multiple foci):
Histologic grade (total score):
Nuclear score:
Tubule score:
Mitosis score:
Ductal carcinoma in situ (DCIS) [Present/Absent]:
aExtent/size of DCIS
aEIC
aGrade
Macroscopic and Microscopic Extent of tumor (only if the structures are present and involved):
Skin:
Nipple:
Skeletal muscle:
a Lymphovascular invasion:
Margins
Invasive carcinoma (Involved/uninvolved):
Distance from closest margin:
aSpecify closest margin:
aFor positive margins, specify extent (focal, minimal/moderate or extensive):
DCIS (DCIS not present, Involved/uninvolved
Distance from closest margin:
aSpecify closest margin:
aFor positive margins, specify extent (focal, minimal/moderate or extensive):
Lymph nodes (required only if lymph nodes are present in the specimen)
Number of Sentinel lymph node(s):
Number of Total lymph node(s) (sentinel and non-sentinel):
Number of lymph node(s) with macrometastases (> 2 mm):
Number of lymph node(s) with micrometastases (> 0.2 mm to 2 mm and/or> 200 cells):
Number of lymph node(s) with ITCs ( > 0.2 mm to 2 mm and/or > 200 cells)
aSize of largest metastasis
aExtranodal extension:
a Treatment effect (if there is neoadjuvant treatment):
Pathologic TNM staging:
Ancillary Studies/ Predictive Markers #:(Breast Biomarker Reporting Template now available on CAP website)
Estrogen receptor (%, intensity and interpretation):
Progesterone receptor (%, intensity and interpretation)
HER2 (Immunohistochemistry and/or FISH Result):
CARCINOMA OF THE COLON OR RECTUM
Specimen:
Procedure:
Tumor site:
Tumor size:
Macroscopic tumor perforation:
Histologic type:
Histologic grade:
Microscopic tumor extension:
Margins:
Distance of invasive carcinoma to closest margins (if all margins are uninvolved):
Specify margin:
Proximal: Uninvolved by invasive carcinoma
Distal: Uninvolved by invasive carcinoma
Mesenteric (radial for rectal cancers):
Treatment effect:
Lymph-vascular invasion:
Perineural invasion:
Tumor deposits (discontinuous extramural extension):
Lymph nodes:
Number of Lymph Nodes Examined:
Number of Lymph Nodes Involved:
Pathologic staging (pTNM):
b Ancillary Studies/ Predictive Markers (Colon and RectumBiomarker Reporting template now available on CAP website)
Immunohistochemistry studies for Mismatch repair protein (MMR):
Microsatellite instability (Also specify testing method):
Methylation studies
BRAF mutational analysis
KRAS mutational analysis
CARCINOMA OF THE KIDNEY
Procedure:
Specimen laterality:
a Tumor site:
Tumor size:
Tumor focality:
Macroscopic extent of tumor:
Histologic type:
Sarcomatoid features:
Histologic grade (Fuhrman Nuclear Grade):
Microscopic tumor extension:
Margins: Tumor present at renal vein margin
Lymph nodes:
Number examined:
Number involved:
Pathologic Staging (pTNM):
Pathologic findings in non-neoplastic kidney:
CARCINOMA OF THE PROSTATE
Procedure:
Prostate weight:
Prostate size:
Lymph node sampling:
Histologic type:
Histologic grade (Gleason pattern):
Primary pattern:
Secondary pattern:
Tertiary pattern
Total Gleason score:
Tumor Quantitation:
Proportion (percent) of prostate involved by tumor:
and/or
Tumor size (dominant nodule, if present):
Extraprostatic extension:
Seminal vesicle invasion:
Margins:
Lymph-Vascular invasion:
a Perineural invasion:
Treatment effect on carcinoma:
Pathologic staging (pTNM):
THYROID CARCINOMA
Procedure:
Specimen Integrity:
Specimen Size
a Specimen weight:
Tumor Focality (For multifocal tumors: Dominant and second tumor nodules need to have the indented data elements completed separately for both; findings on additional nodules should be recorded in additional findings):
Tumor Laterality:
Tumor Size:
Histologic Type:
a Histologic grade:
Margins:
Tumor capsule:
Tumor capsular invasion:
Lymph-Vascular Invasion:
Extrathyroidal Extension:
Number lymph nodes examined:
Number lymph nodes involved:
Pathologic Staging (pTNM):
Additional findings:
ENDOMETRIAL CARCINOMA
Specimen:
Procedure:
Lymph Node Sampling:
Specimen Integrity:
a Tumor Site:
Tumor Size:
Histologic Type:
Histologic Grade:
FIGO Grading System for endometrioid and mucinous adenocarcinomas only):
Grading for other carcinomas (well to poorly differentiated):
Myometrial Invasion:
Depth of invasion:
Myometrial thickness:
Involvement of Cervix:
Extent of Involvement of Other Organs:
a Peritoneal Ascitic Fluid:
Lymphovascular Invasion:
Stay updated, free articles. Join our Telegram channel
Full access? Get Clinical Tree
Get Clinical Tree app for offline access
